Research at the University of Southampton is looking at how immunotherapy can enable the body’s immune system to recognise and kill cancer cells.
Immunotherapy: Cancer Assassin
Targeting Tumors: Challenges of Antibody-Drug ConjugatesVideo
More than two dozen ADCs are currently being used in the clinic to treat diseases like Hodgkin's lymphoma and breast cancer, and researchers are developing many more. But it's taken decades to find the right combination of drug, antibody target and linker, and then make sure the right amount of ADC hits the tumor.
Comments | 0 ADD COMMENT
27th International Conference on Nanomedicine and Nanomaterials
Oct 18 - Oct 19, 2018